A Novel Artificial Intelligence–Powered Method for Prediction of Early Recurrence of Prostate Cancer after Prostatectomy and Cancer Drivers

Wei Huang, Ramandeep Randhawa, Parag Jain, Samuel Hubbard, Jens Eickhoff, Shivaani Kummar, George Wilding, Hirak Basu, Rajat Roy

Research output: Contribution to journalArticlepeer-review

Abstract

PURPOSE To develop a novel artificial intelligence (AI)–powered method for the prediction of prostate cancer (PCa) early recurrence and identification of driver regions in PCa of all Gleason Grade Group (GGG). MATERIALS AND METHODS Deep convolutional neural networks were used to develop the AI model. The AI model was trained on The Cancer Genome Atlas Prostatic Adenocarcinoma (TCGA-PRAD) whole slide images (WSI) and data set (n = 243) to predict 3-year biochemical recurrence after radical prostatectomy (RP) and was subsequently validated on WSI from patients with PCa (n = 173) from the University of Wisconsin-Madison. RESULTS Our AI-powered platform can extract visual and subvisual morphologic features from WSI to identify driver regions predictive of early recurrence of PCa (regions of interest [ROIs]) after RP. The ROIs were ranked with AI-morphometric scores, which were prognostic for 3-year biochemical recurrence (area under the curve [AUC], 0.78), which is significantly better than the GGG overall (AUC, 0.62). The AI-morphometric scores also showed high accuracy in the prediction of recurrence for low- or intermediate-risk PCa—AUC, 0.76, 0.84, and 0.81 for GGG1, GGG2, and GGG3, respectively. These patients could benefit the most from timely adjuvant therapy after RP. The predictive value of the high-scored ROIs was validated by known PCa biomarkers studied. With this focused biomarker analysis, a potentially new STING pathway–related PCa biomarker—TMEM173—was identified. CONCLUSION Our study introduces a novel approach for identifying patients with PCa at risk for early recurrence regardless of their GGG status and for identifying cancer drivers for focused evolution-aware novel biomarker discovery.

Original languageEnglish (US)
Article numbere2100131
JournalJCO Clinical Cancer Informatics
Issue number6
DOIs
StatePublished - 2022
Externally publishedYes

ASJC Scopus subject areas

  • Oncology
  • Health Informatics
  • Cancer Research

Fingerprint

Dive into the research topics of 'A Novel Artificial Intelligence–Powered Method for Prediction of Early Recurrence of Prostate Cancer after Prostatectomy and Cancer Drivers'. Together they form a unique fingerprint.

Cite this